News

Eurostars R&D Project, Jan 2017

ImmunoSYS has started a 2-year project, ‘COMPIT’, to research and develop a novel in vitro human immune analytical platform for preclinical drug immunogenicity testing. The project is in collaboration with the Dutch company Abundnz BV and receives a EU funding through the Innovate UK.

 

Welcome to ImmunoSYS

home1

INNOVATIVE BIO-ANALYSIS

ImmunoSYS is an analytical service providing company specialising in immunologic and ultra-sensitive assays. We bring innovative solutions to biological analysis.

  • Are you involved in large molecules drug discovery?
  • Or research that involves proteins and the interaction with the immune system?

We have innovative and advanced systems that could help your work significantly.

The preclinical stage of drug development is a critical phase that takes a new investigational drug through efficacy and safety tests in non-human studies to the human studies in clinical phase. Assays that can be predictive of outcomes in human trials are of highest priority. ImmunoSYS is focused in developing and providing solutions in the immunology of drugs at this stage. Our innovative platform of comprehensive immunologic and pharmacokinetic analyses is a step towards understanding the safety of drugs before they are studied in humans.

 

EUROSTARS PROJECT

ImmunoSYS is recipient of a 2-year Eurostars R&D project grant in partnership with Abundnz BV (Netherlands). The project COMPIT started in Jan 2017 at the BioHub at Alderley Park and is focused on studying the immunology of drug-induced tissue damage. The outcomes of the project is expected to develop a novel and robust preclinical in vitro cellular system for the analysis of immunological risk of drug compounds.

 

BIOTECHNOLOGY DEVELOPMENT

ImmunoSYS is particularly focused in providing solutions in biotechnology dependent businesses. We help in building up capacity in biological systems that will help your business grow in agribusiness or biopharmaceuticals.

  • Are you interested in biotech related industry?
  • Do you want to develop capacity for your company in biological systems?
  • Is the biological market in your region growing and are you prepared for it?

Go to link page here

What We Do

home2

Biological capacity development

Analytical services (biomolecular)

Modelling of biological mechanisms

Research

We work with organisations of all sizes including academic institutes, life science investors, start-up companies and established organisations.

ImmunoSYS is an R&D focused company. We work together with academia and biotech groups to develop innovative products and systems through research.

 

NEW VENTURE IN DRUG SAFETY ANALYSIS

ImmunoSYS and Abundnz BV joined forces and started a new CRO, Immundnz (www.immundnz.com) in 2017, that offers an innovative platform for the comprehensive immune analysis of drug molecules. Immundnz has its laboratory based at the BioHub at Alderley Park in Cheshire (UK).